{"name":"Bio-Rad Laboratories","slug":"bio-rad","ticker":"BIO","exchange":"NYSE","domain":"bio-rad.com","description":"Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.","hq":"Hercules, CA, USA","founded":0,"employees":"7450","ceo":"Norman Schwartz","sector":"Clinical Diagnostics / Life Science Research","stockPrice":283,"stockChange":5,"stockChangePercent":1.8,"marketCap":"$7.6B","metrics":{"revenue":2600000000,"revenueGrowth":3.9,"grossMargin":52,"rdSpend":275600000,"netIncome":759900000,"cash":1540700032,"dividendYield":0,"peRatio":10.2,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"QX-265 patent cliff ($100M at risk)","drug":"QX-265","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Bio-Rad Laboratories Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Bio-Rad Laboratories reported its fourth quarter and full year 2023 financial results, with revenue of $1.43 billion and net income of $234.8 million.","drugName":"","sentiment":"positive"},{"date":"2023-09-06","type":"deal","headline":"Bio-Rad Laboratories Acquires Cloud-Based Laboratory Information System Provider","summary":"Bio-Rad Laboratories acquired a cloud-based laboratory information system provider to expand its offerings in the clinical diagnostics market.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-02-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNU0Y3bGYzQ2JSWTBycXNJUzJfbHNFYXE5RkpkT0xVcURLT01NTEtSUlBqbXBzZ2tSYkVyVkkxSnVuOENyNmpaVzJSRlgyZ1MzejRmQURVMXpkQUlmMmpsM2N2NHlWRE5iMTR3NUhGWTFSUDJmN09QaGdXeVNyWHFUX2FIVF8xekdTbG51NWlKYzhWUWNBd2h5bWZzbkZQUlF6dkoxQg?oc=5","date":"2026-02-13","type":"pipeline","source":"TradingView","summary":"BIO-RAD LABORATORIES, INC. SEC 10-K Report - TradingView","headline":"BIO-RAD LABORATORIES, INC. SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOdy1IR0tvZ25HUGowMjByem5DQzdpYWt4WWpIUEZwMGNueG5LSmtBNXJMWFFkN0pfV3VuSnBlX0UxOVZWdllZLXRQb1VjbVg3eXpLd0ZrMUlySzc3NFhQYmRzQ2xLS1hCMmNPSGU4SWpYUHF3MV9icDI4RnNKeEludUZJMWdHYnVPMVZBZWp1T2l3NkZZakRPTjVnWmlZbk83bm13N3RjdXhxbk9oVFpVdWhubzQ?oc=5","date":"2026-02-13","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Friday's Pre-Market Session","sentiment":"neutral"},{"date":"2026-02-13","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOaVJVRldlOUtVbXpDb3FBb21heU9sSW1mM1ZHTUlrVDlBNV9QSXZDVkxONkduc1FOQWtsUlJ6THNjd3YzNnotYW9UR3BpaG54VGNSSWZlVldWR2gwUVFuV1k1RzRGa21LMXExaTlGb1RTSU5oLS1ZUEFuUWZQdGxWaFR2WGdaS2lhbEg2S3VOQzZ1Vzk2Q1VaV0FLbEVJbEhXMlNXT09ZejBIWG1uZEV3UnhKdU5kSFBaT3FUeWZGTEJqRGV1c3c?oc=5","date":"2026-01-04","type":"pipeline","source":"AD HOC NEWS","summary":"Bio-Rad Laboratories: Quiet Consolidation Or Coiled Spring in Life-Science Tools? - AD HOC NEWS","headline":"Bio-Rad Laboratories: Quiet Consolidation Or Coiled Spring in Life-Science Tools?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOOVU5Y0c0Q1lpaVJ1SXhiSW9Fbmc4YUxsUGJvTWFMTGdQQVhVXzk4T2JabnJKY2ZZbVVqbEdJczd1cUF5TTRSYVRiMVRUTWNRVWkyakg4TmZRY0NJbFhrSHNUdjBWTUl4bEFWaVQtWVhlOWc0d3pXeElCeUxfcVBnMTdxaXVTWlR1TjR5Tjc1VWhJb0xrQnlBcWNOdU9yb1NfYzV1U2ZETGVtZkRHeXJTanhqMVJuSW1TWF9tVm5rRkRHTWRVWklueQ?oc=5","date":"2025-11-10","type":"pipeline","source":"BioPharma APAC","summary":"Top Global Proficiency Testing Companies Setting New Standards in Laboratory Accuracy - BioPharma APAC","headline":"Top Global Proficiency Testing Companies Setting New Standards in Laboratory Accuracy","sentiment":"neutral"},{"date":"2025-10-29","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-10-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQOWtvTklpY19rWWI0d2NMTnd0b0lZNGtNS1B4X19nclBDNzJLMFRxMVRZLXVHRjBmSWZYa0VnekNBZHRTUFIxTnBnYng1OTBKUmhDS1ZZaHBubnRkSkNtZzBaXzFaUnI0dU82N3dONkNYWF9Fa3hETExHa1RRMFpObDR0OS1zX2xlSm02b1Rob3pndGF2U1Y5RzZzUXJjVXluaXVNNGdjbjN6Y3d0R1ZxMm5LSERRaGpwMWgyTE1YUVo?oc=5","date":"2025-10-24","type":"deal","source":"Clinical Lab Products","summary":"Biodesix Expands Bio-Rad Partnership for Droplet Digital PCR Assay Development - Clinical Lab Products","headline":"Biodesix Expands Bio-Rad Partnership for Droplet Digital PCR Assay Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNc0RkN1VvOVBnMmFGdUUyVnVsNm1LUzM0ZmlFaEJ3M2FITlBiam54UjVfNmRmWUF4d1pTSHExZW5HTHBSMGhIRU5KalV0UXFPdkhzRHE4VlRfZ2dvU2p3SjBPcGZaZmd2R2FhT01OSVpTSXdGWlRYSE5Ic3BaWHI1cmo4LVN5clVZa2xITm1ZWlNQY1lJQzdwZlBiUFdVYzE4aDB1STlBWHBKaUpGWEEzMmhZcnhmMzNKMkttMHh0WlBGSEpuMFYw?oc=5","date":"2025-10-23","type":"deal","source":"Drug Discovery News","summary":"Biodesix expands Bio-Rad partnership to enable advanced genomic testing in breast cancer - Drug Discovery News","headline":"Biodesix expands Bio-Rad partnership to enable advanced genomic testing in breast cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPeHkwYTdKWFdNNjFiSE9SSmdRSE9xXzlMVmk0TWQzdGdXdTI3LTBlNER2eVlXanNlWnJac0MxUWg1VTVpTFZMWDhPSlBGWUNzYXh2eTFGN2UyUjVwaDVSUDNhSmtFMzU5LXo3aWNXTjdLRFg2YTBKNjVoTE83RmttM3FmUldZTGtxMklNNXhTWTUxVXZOZ0hNNUVFSUlDNmpQaFhqTzBwSm5Gck9pSGdKZm40empNZw?oc=5","date":"2025-10-22","type":"pipeline","source":"Stock Titan","summary":"Biodesix (NYSE: BDSX) to validate ddPLEX ESR1 assay; IVD filings and CLIA-CAP service - Stock Titan","headline":"Biodesix (NYSE: BDSX) to validate ddPLEX ESR1 assay; IVD filings and CLIA-CAP service","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOTUlPY1dpWVpyd2JKbjlyTG0zNTJFdnBZUHMxT0N1MUNka0pIRHRxLUU1UlU5Wkh3S0k4ZzFINXRScXROczJPX3hKNEN4aE90Nkx4ZEhBNFE5QmxoQk5ZVTluVzNUNHNzRlF3MEctWTlZN0dxa29xQWpjbXpTMTFZT3QzbVctdEE4aDRaXzlOUHVwYTJ6T3YtSFA0WE11OGJCaFBBSTN2ZTNOUy12UU5RRmliOV92NkNtUnpB?oc=5","date":"2025-10-06","type":"deal","source":"Pharmafile","summary":"Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits - Pharmafile","headline":"Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits","sentiment":"neutral"},{"date":"2025-09-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPeGIxMldmeEFINWZlbGVVYnBtWWhwZ3ZGZk9TNUV5emhZVVN3Rk42emdjcVlHaVdmeUdMZF9LVEV4dlBxdHI0Um9BLTdtTVVKR1JvWXhnMXI5YmRqczVnbkdtUWhST2ZoN2YxWmpUajJITlhIUUtubl8ySDQxT2NSbzRjb2hmbmZQV0Y1QlcxZlllVEUyWkQ5akJubEcwU1Z4Vl91S1J2MUJkUQ?oc=5","date":"2025-08-26","type":"pipeline","source":"Contract Pharma","summary":"Bio-Rad Laboratories Introduces New Range of StarBright Dyes - Contract Pharma","headline":"Bio-Rad Laboratories Introduces New Range of StarBright Dyes","sentiment":"neutral"}],"patents":[{"drugName":"QX-265","drugSlug":"qx-265","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Thermo Fisher Scientific","Danaher Corporation","Siemens Healthineers"],"therapeuticFocus":["Infectious Diseases","Oncology","Autoimmune Disorders"],"financials":{"source":"sec_edgar","revenue":2583200000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":2583200000,"period":"2025-12-31"},{"value":2566500000,"period":"2024-12-31"},{"value":2566500000,"period":"2024-12-31"},{"value":2671300000,"period":"2023-12-31"},{"value":2671200000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":275600000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":759900000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":10576500000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":283,"previousClose":278,"fiftyTwoWeekHigh":343.12,"fiftyTwoWeekLow":211.43,"fiftyTwoWeekRange":"211.43 - 343.12","fiftyDayAverage":279.12,"twoHundredDayAverage":288.52,"beta":1.16,"enterpriseValue":7347429376,"forwardPE":25,"priceToBook":1.02,"priceToSales":2.96,"enterpriseToRevenue":2.84,"enterpriseToEbitda":17.02,"pegRatio":0,"ebitda":431600000,"ebitdaMargin":16.7,"freeCashflow":256550000,"operatingCashflow":532200000,"totalDebt":1384800000,"debtToEquity":18.6,"currentRatio":5.62,"returnOnAssets":1.7,"returnOnEquity":10.8,"analystRating":"2.5 - Buy","recommendationKey":"buy","numberOfAnalysts":4,"targetMeanPrice":302.5,"targetHighPrice":320,"targetLowPrice":280,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":16.2,"institutionHeldPercent":90.4,"sharesOutstanding":21924404,"floatShares":21134288,"sharesShort":34,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":27.86,"epsForward":11.34,"revenuePerShare":94.69,"bookValue":276.16,"officers":[{"age":75,"name":"Mr. Norman D. Schwartz","title":"Chairman & CEO"},{"age":59,"name":"Mr. Jonathan P. DiVincenzo","title":"President & COO"},{"age":54,"name":"Mr. Roop K. Lakkaraju CPA","title":"Executive VP & CFO"},{"age":47,"name":"Mr. James J. Barry","title":"Executive VP & President of Life Science Group"},{"age":46,"name":"Mr. Rajat  Mehta","title":"Executive Vice President of Global Commercial Operations"},{"age":null,"name":"Mr. Yong  Chung","title":"Vice President of Investor Relations"},{"age":null,"name":"Matthew  Werner","title":"Senior VP and Chief Compliance & Privacy Officer"},{"age":53,"name":"Ms. Courtney C. Enloe","title":"Executive VP, General Counsel & Secretary"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.bio-rad.com","phone":"510 724 7000"}}